Alembic Pharmaceuticals receive USFDA nod for Fenofibrate tablets
Alembic Pharmaceuticals receive USFDA nod for Fenofibrate tablets

Alembic Pharmaceuticals receive USFDA nod for Fenofibrate tablets

Anthony Fernandes Article rating: 5.0

Alembic Pharmaceuticals announced that it has received final approval from US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Fenofibrate tablets USP, 54 mg and 160 mg. The approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product Tricor tablets, 54 mg and 160 mg of AbbVie Inc.

Myths regarding fixed income investments
Myths regarding fixed income investments

Myths regarding fixed income investments

Henil Shah Article rating: 5.0

Fixed income investment has been one of the most preferred investments traditionally. However, there are certain myths with respect to fixed income investments that need to be busted. Let’s find out what are they!

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 5.0

The market opened in the green on 23rd January, overall volumes in futures & options currently stand at 2.36 crore contracts with a turnover of Rs. 16,74,537.87 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 4.7

The market opened in the green on 23rd January, overall volumes in futures & options currently stand at 2.36 crore contracts with a turnover of Rs. 16,74,537.87 crore.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 4.0

The market opened in the green on 23rd January. The previous day witnessed the Sensex going down by 208.43 points to end at 41,115.38 and the Nifty was down by 62.95 points to close at 12,106.90.

Retail investors form 90 per cent of domestic MF investors
Retail investors form 90 per cent of domestic MF investors

Retail investors form 90 per cent of domestic MF investors

Shashikant Singh Article rating: 5.0

The Asset under Management (AUM) of domestic mutual fund industry has more than doubled in the last few years. It is the increased participation of retail investors that has helped to record such a growth.

Dilip Buildcon inches higher on EPC order execution
Dilip Buildcon inches higher on EPC order execution

Dilip Buildcon inches higher on EPC order execution

Pratik Shastri Article rating: 5.0

The company released a press note to stock exchange informing that it has executed an EPC agreement with Uttar Pradesh Expressways Industrial Development Authority (UPEIDA) for project scope in the state. 

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 4.5

The market opened in the green on 23rd January. The previous day witnessed the Sensex going down by 208.43 points to end at 41,115.38 and the Nifty was down by 62.95 points to close at 12,106.90.

Axiscades Engineering zooms on strong order offtake
Axiscades Engineering zooms on strong order offtake

Axiscades Engineering zooms on strong order offtake

Pratik Shastri Article rating: 2.6

The Aerospace customer has renewed contract with an increase scope of delivery and additional areas of business. The company also signed a new contract with Heavy Engineering customer in North America. 

RSS
First24022403240424052407240924102411Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR